News
A-REIT's Proposed Acquisition Of Neuros & Immunos For S$125.6 Million
BackMar 31, 2011
| Title |
|
|
| Acquisitions and Disposals |
|
|
| Description | ||
Attachments
- Announcement (Size: 96,280 bytes)
- Presentation (Size: 362,996 bytes)
| Title |
|
|
| Acquisitions and Disposals |
|
|
| Description | ||
Attachments
The information behind this electronic gatepost is only being made available to residents of Singapore, and may not be reproduced or redistributed or passed on in whole or in part, directly or indirectly, to any other person for any purpose. The distribution of the information behind this electronic gatepost in certain jurisdictions may be restricted by law, and persons into whose possession such information comes should inform themselves about, and observe, any such restrictions.
Nothing on this website is an offer to sell or a solicitation of an offer to purchase any securities. In particular, the units of CapitaLand Ascendas REIT (the "Units") have not been and will not be registered under the United States Securities Act of 1933, as amended (the “US Securities Act”) or the securities laws of any state or other jurisdiction of the United States, and may not be offered or sold in the United States unless registered under the US Securities Act, or pursuant to an applicable exemption from registration and in compliance with applicable state laws. Nothing on this website shall constitute a public offer of securities in the United States or in any jurisdiction in which such offer would be unlawful. The Units are only being offered and sold (i) outside the United States in reliance on Regulation S under the US Securities Act ("Regulation S") to non US persons who are eligible to invest in offshore transactions (as defined in Regulation S); and (ii) in the United States solely to qualified institutional buyers (as defined in Rule 144A under the US Securities Act ("Rule 144A")) pursuant to Rule 144A or other applicable exemptions under the Securities Act. The information provided on this website is not to be accessed, published, forwarded or otherwise distributed in or into the United States.
By clicking on the “I agree” button below, you will have acknowledged the foregoing restrictions and represented that you are resident in Singapore and are not accessing this website from jurisdictions outside of Singapore, including the United States.